Today, 106 organizations representing patients, providers, medical researchers, survivors, and families joined together to urge Congress to include the bipartisan CLINICAL TREATMENT Act (H.R. 913) in the upcoming ‘must pass’ healthcare extenders package, which is expected to pass this spring.
February 18, 2020
February 7, 2020
Thirty-three practices in three countries have committed to providing high quality care by receiving the Quality Oncology Practice Initiative (QOPI®) Certification in the fourth quarter of 2019. The Association for Clinical Oncology (Association) applauds the work of these practices to ensure a better and healthier future.
February 6, 2020
2019-20 ASCO President Howard Burris III commends CMS for reflecting recommendations in the Society’s position statement on pharmacy benefit managers in the agency’s 2021 and 2022 Medicare Advantage and Part D proposed rule.
February 4, 2020
The emergence of novel systemic therapies — combined in new and better ways — has significantly changed the role of cancer surgery. In recognition of the substantial progress made in this area in the past year, in Clinical Cancer Advances 2020 — just released today— the American Society of Clinical Oncology (ASCO) has named is the Refinement of Surgical Treatment of Cancer as the Advance of the Year.
January 28, 2020
The American Society of Clinical Oncology released a position statement, “Block Grants in Medicaid & Their Impact on Cancer Care,” summarizing the Society’s concerns about the potential negative impact that recent proposals to establish annual limits on federal funding for Medicaid—or block grants—could have on patients with cancer.
January 24, 2020
Positive findings from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study cohorts on the potential benefit of various molecularly targeted drugs in patients with advanced colorectal cancer will be presented at the 2020 Gastrointestinal Cancers Symposium, taking place January 23-25, 2020 at the Moscone West Building in San Francisco, California.
January 23, 2020
Statement by ASCO President Howard A. "Skip" Burris III, MD, FACP, FASCO, applauding the Surgeon General for releasing its first report on smoking cessation in 30 years.
January 21, 2020
A retrospective analysis of 26,768 young adults age 40 and under found that those who live in areas with lower income (less than $38,000) and lower education (under 79% high school graduation rate), as well as those who live in urban areas, had worse outcomes and a higher risk of death.
January 21, 2020
Patient-reported outcomes from two large studies show that quality of life is maintained longer with newer drug combinations compared with standard of care for the treatment of patients with a specific type of colorectal cancer and unresectable hepatocellular carcinoma.
December 19, 2019
ASCO applauds Congress for working across party lines to raise the minimum age for purchasing tobacco products to 21 and for continuing its commitment to investing in our nation's biomedical research infrastructure.
December 18, 2019
Nine oncology practices from rural and urban centers in the U.S. that primarily treat underserved populations have received grant funding to participate in the American Society of Clinical Oncology’s (ASCO) Quality Oncology Practice Initiative (QOPI®) and Quality Training Program. ASCO announced today the recipients of the grants, which are supported by the Stavros Niarchos Foundation.
December 17, 2019
The American Society of Clinical Oncology (ASCO) has elected Everett E. Vokes, MD, FASCO, a long-time member and volunteer, to serve as its President for the term beginning in June 2021.
December 12, 2019
ASCO President Howard "Skip" Burris congratulates Dr. Stephen Hahn on his confirmation to serve as Commissioner of the U.S. FDA.
November 26, 2019
On November 26, 2019, ASCO released a major update to its Patient-Centered Oncology Payment (PCOP) model, an alternative payment model designed to support transformation in cancer care delivery and reimbursement while ensuring that patients with cancer have access to high-quality, high-value care.
November 14, 2019
Two science-based organizations—CancerLinQ LLC, a nonprofit subsidiary of the American Society of Clinical Oncology, and the American Heart Association, the leading voluntary health organization devoted to a world of longer, healthier lives—are teaming up to make oncology datasets from the CancerLinQ Discovery® database available to academic researchers, non-profits, health care providers and government agencies through a customized version of the American Heart Association’s Precision Medicine Platform.
Pages |